BIOMARIN PHARMACEUTICAL INC - Director's Dealing 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-02-20

Reporting Person: Davis George Eric (SVP, General Counsel)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-20	Common Stock	M	20000	$21.51	Acquired	80656	Direct
2014-02-20	Common Stock	S	20000	$80.00	Disposed	60656	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-20	Stock Option (right to buy) Common Stock	$21.51	M	20000	Disposed	2020-05-11	Common Stock (20000)	Direct

F1: This transaction made pursuant to a Rule 10b5-1 trading plan executed on December, 11, 2013.

F2: All shares sold at the same price

F3: Original option grant vests 6/48ths on November 12, 2010 and 1/48th on the 12th day of every month thereafter.

F4: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.